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The purpose of this research paper is to better 
understand the disease Tuberculosis. There are five main 
areas of interest: Global Statistics on Prevalence. Drug 
Resistance. Immigration. Human Immunodeficiency 
Virus/AcqUlred Immune Deficiency Syndrome. and Future 
Proorams and Goals. These five areas wil I be discussed in 
this caper. The researcher will describe how these items 
hinde~ publ ic health officials from eradicating 
Tuoercuicsis. The paper begins with a general overview of 
Tuber=ulcsis and then progresses to an in-depth explanation 
of each topic. 
t 
Description of Tuberculosis 
TubeLculosis is an infectious disease caused by the 
bacteLia Mycobacterium tuberculosis. a bacterial organism. 
It is tLansmitted to others pLimarily through means of the 
aiL by things such as coughing. sneezing, or even breathing. 
The majoLity of people who aLe infected with TubeLculosis do 
not have any symptoms. Many people have what is called 
latent Tuberculosis. Latent Tuberculosis occurs when a 
peLson is infected with the disease but there are no 
symptoms and the disease is not contagious. Some people may 
neveL aevelop active Tuberculosis while others may progress 
from latent Tuberculosis to active Tuberculosis within two 
years of the time of infection. Active Tuberculosis occurs 
when the individual develops symptoms and becomes contagious 
<MMWP). Most people are not diagnosed with Tuberculosis 
unti I it becomes active. Active Tuberculosis can be 
identified by the fol lowing symptoms: malaise. easy fatigue. 
anorexia. weight loss. sl ight fever. chronic cough. and in 
extLeme cases pulmonary bleeding. Most cases will not have 
~l I symptoms (HaLris). 
Doctors can diagnose Tuberculosis using a Tuberculosis 
skin test. A small amount of the Tuberculosis bacteria is 
injected under the skin. The nurse or doctor will then 
check the point of in,iection 72 hours after the test. If 
the patient is positive for Tuberculosis there wi I I be a 
raised portion of the skin. The doctor may then have an 
X-ray of the patient/s lungs as well as a sputum smear. A 
sputum smear consists of I iquid that has been excreted from 
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the lungs. The doctor may do a culture on this excretion to 
test for Tuberculosis (Harris). 
Once Tuberculosis has been diagnosed a patient must 
begin treatment immediately. The treatment consists of a 
form of chemotherapy administered dai ly in the form of a 
capsuie cr pil j. The treatment lasts from 6 months to one 
lear. Therapy must continue for the full period in order to 
De effective. 
z 
Global Statistics and Prevalence 
--
In the year 1990 there were an estimated 7.5 mill ion 
cases of tuberculosis reported. Although the majority of 
the cases occurred in third world countries. the largest 
increase has occurred in developed nations. Ninety-five 
percent of Tuberculosis cases were found in developing 
nations where tuberculosis was the number one cause of 
morbidity. Mortality resulting from Tuberculosis was as 
high as 60% worldwide at one time. but is declining due to 
various types of treatments. In 1990 there were 2.5 mil I ion 
deaths caused by tuberculosis. Ninety-eight percent of 
these deaths occurred in developing nations. It is 
proiectea that from 1990 to 1999.90 million new cases of 
TU[JerGl~ los 1 s \,71 i i occur ,-lor I dH 1 (Ie. Tubercu I os is 1 s the 
Horld(s foremost cause of death from a single infectious 
~gent (Raviglione. et ~l). 
The statistics seem overwhelming. There is an enormous 
numbe: of tuberculosis cases in the world and the rate 
continues to rise. It is easy to see that Tuberculosis is 
not only a problem for the United States but for the rest of 
the world as well. Researchers have developed a scale 
cal led the Average Annual Risk of Tuberculosis Infection 
(ARTI). This scale uses current prevalence to predict the 
probability that an individual Hill become infected with 
Tuberculosis within one year. The ARTI was found to be high 
in sub-Saharan Africa. South and East Asia. North Africa. 
the Middle East. and Central and Latin America (Raviglione 
et a I ) . 
--
In the United States tuberculosis cases decreased 
approximately 5.3% per year from 1953 to 1984. After 1984. 
however. Tuberculosis began to rise. From 1984 to 1993 the 
numDer of cases in the U.S. increased by 14%. All age 
groups with the exception of those 65 and older experienced 
an increase in Tuberculosis. The group with the largest 
increase was the 25-44 year old age group. More than 70% of 
the new cases in the United States were reported in ethnic 
minority groups. The United States has experienced 
Tuberculosis outbreaks in hospitals. prisons. residential 
care faci I ities for AIDS patients. nursing homes. and 
homeless shelters. Clearly. Tuberculosis is a serious 
problem for the U.S. (Ravigl ione et al). 
In Europe. however. cases of Tuberculosis declined 
unti I 1992. In some European areas the number of cases has 
leveled cff and a small number of countries has recently 
experienced a rise. Switzerland has experienced a 40% 
increase between 1986 and 1990 but from 1990 to 1992 a 
decrease was found. The highest rate of Tuberculosis in 
Europe was found in Portugal and the lowest European rates 
were found in Denmark and Sweden. Overall. European 
countLies have reported less than 25 cases per 100.000 
people. 
Developing nations have extremely high rates of 
TUDercuiosis infection. Tanzania reported 3.369 
Tuberculosis cases per 100.000 people from 1990 to 1992. 
Tuberculosis accounts for 25% of the avoidable adult deaths 
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In developIng countries. Ninety-eight percent of al I 
tuoerculosls related deaths occurred in developing nations. 
Without proper action tuberculosis wil I continue to progress 
and tne number of deaths wil j continue to rise. 
Learning about Tuberculosis globally can open the eyes 
of both health care providers and health educators in the 
United States. It is possible that such individuals may one 
day work in some way with the World Health Organization or 
even the Department of Health and Human Services. It is 
important that the United States make a commitment to 
eradicating tuberculosis not only in this country but in the 
rest of the world as well. We have resources and technology 
that developing nations do not have access to and often 
cannot afford. Many developing nations also lack the proper 
knowledge needed to fight this disease. By helping other 
nations in the world the United States will help itself. We 
must remember that we are not enclosed in a bubble: 
everything that happens in the world affects us an a nation. 
Tuberculosis rates in other countries play an important role 
in the health of the U.S. because of the vast number of 
legal ana il legal immigrants entering the U.S. and the 




-Tuberculosis has recently donned a new image. Doctors 
are now ciscovering cases of Tuberculosis that are resistant 
to one or more treatment medications. This type of 
Tuberculosis is referred to as drug resistant tuberculosis. 
Many health professionals are wondering how drug resistant 
tUberculosis came into being. 
Two main ways that a person can develop drug resistant 
tuberculosis are primary resistance and acquired resistance. 
Acqui~ed resistance occurs when a person has received 
treatment for TUDerGuloBiB in the PdBt. If d patient dia 
not fol lew the doctors orders when taking medication or if 
the doctor prescribed an incorrect treatment regimen. a 
patient ~ay aevelop drug resistant Tuberculosis CRavlgllone 
et a. i) , It is helpful to compare drug resIstant 
Tuberculosis to immunizations. When a child receives an 
immunization he receives a smal I dose of the disease so that 
his body wil I bui ld up a defense system against that 
aisease. When the chi ld is exposed to the disease later in 
life his immune system wi I 1 be capable of defending him. In 
a similar way. if the disease causing organism has already 
Deen exposed to a medication it is able to build up a 
tolerance for that particular drug. When the Tuberculosis 
is treated a second time it wi I I not react to the original 
medication. Acquired drug resistant Tuberculosis is common 
among developing nations where it is difficult to afford 
medication and also difficult to monitor patients over the 
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iong oerloa of treatment <ranging from 3 months to 1 year). 
It may also occur when a physician does not prescribe the 
medication in accurate doses or for the correct length of 
time (Ravilgione et al) .. 
~rimarv resistance to medication occurs in patients who 
have never received prior treatment. If a person who has 
acquired resistance transmits the disease to a person who 
does not have Tuberculosis. the new case wil I be resistant 
to the same medication that the acquired person was 
resistant to. In other words. when a Tuberculosis case 
becomes immune to a certain medication. each person who 
contract~: the disease from the immune individual wi I I also 
be immune (Ravigl ione et al). Therefore. it is extremely 
important to prevent transmission of acquired drug resistant 
Tuberculosis. 
If a person has drug resistant Tuberculosis. he/she 
does not have to throw in the towel yet. It is possible to 
treat Tuberculosis with several types of medications. Once 
the health care worker learns that a patient is resistant to 
one drug he can change the treatment regimen. Some third 
world countries have high rates of death resulting from drug 
resistant Tuberculosis because they do not have the tests 
used to identify drug resistant Tuberculosis cases 
(Raviglione et al). 
Drug resistant Tuberculosis needs to be addressed 
immediately because the longer it is put off the larger the 
problem becomes. One compl ication of drug resistant 
tuoerculcsis is multi-drug resistant Tuberculosis. or 
MDR-TB. This condition occurs when a patient is resistant 
to two of the medications used to treat Tuberculosis. 
Tuberculosis case is found that resists isoniazid and 
If a 
rifampin then it is classified as MDR-TB. In November of 
1992 the Centers for Disease Control and Prevention 
identified 297 cases of MDR-TB within a total of 9 
tuberculosis outbreaks in the U.S. Most. but not all. of 
the MDR-TB outbreaks were found among HIV positive 
populations. The mortality rate among individuals with 
MDR-TB is 70%. The median interval between diagnosis and 
death is 4 to 16 weeks (Ravigl ione et al). While this 
investigator could not find research defining why MDR-TB was 
found among HIV positive individuals. it may be possible 
that the high mortality rates are due in part to the 
weakened immune system of HIV positive patients. In 
addition. MDR-TB is likely to be difficult to treat because. 
whi Ie doctors are trying to find a treatment regimen. the 
Tuberculosis is worsening. 
Earlier. the methods of treatment for patients with 
both Tuberculosis and HIV/AIDS were discussed. The 
treatment often will require many different medications at 
the same time. That may be one reason that AIDS patients 
are susceptible to MDR-TB. 
Drug resistant tuberculosis is a major obstacle to 
eradicating Tuberculosis. The spread of Tuberculosis is 
already en the rise and the last thing that health care 
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workers need to face is drug resistant Tuberculosis. ThE 
problem. however. is already present and without education 
and proper actions this form of tuberculosis wi! J spread. 
Accurate fol low up and testing of al I tuberculosis patients 
is a must in order to prevent and identify al I drug 
resistant cases of Tuberculosis. If a patient has MDR-TB 
and cannet be treated. then he/she must be isolated for the 
healt~ of the community. Reaching out to third world 
countries who are lacking in appropriate testing measures 





310bal statistics are important because the health of 
other nations affects the health of the United States in 
various ways. The author will now focus on the impact that 
immigration is having on the tuberculosis infection rates in 
the U.S. Immigrants to the United States have been found to 
playa role in the recent increase in Tuberculosis cases. 
From 1980 to 1990 the foreign born population in the United 
States increased 40%. The top five countries on the 
immigration I ist were Mexico. the Phi I ippines. Vietnam. 
China. and Korea. These five countries have a rate of 
Tuberculosis that ranges from 10 to 30 times the rate of 
Tuberculosis in the U.S. Other immigrants may come from 
countries where the risk of infection is 100 to 200 times 
the risk found in the United States (Mckenna et al). 
The U.S. requires that al I immigrants applying for 
permanent legal residency pass a sputum smear test before 
entering the U.S. If the test result is positive the person 
must begin treatment and acquire a negative test result. 
This individual is allowed into the United States while 
sti] J positive for Tuberculosis but is required to receive a 
check-up from a health care worker in the U.S. Only with 
approval of a negative test result in the Unites States is 
the immigrant allowed to remain. However. it should be 
noted that individuals who are visiting and students from 
other countries are not required to take any test at al I 
(Iv1ckenna eta I ) . 
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Furthermore. it is possible for immigrants to take 
enough medication to achieve a negative test result for 
Tuberculosis and then stop taking the medication before the 
treatment regimen is complete. This may result in drug 
resistant Tuberculosis which was discussed earlier in this 
pap e r . I fan 1 mm i gr ant has a po sit i ve c he s t x - raj' i tis 
possiole for him/her to purchase a healthy x-ray and 
present it as his/her own in the United States. One must 
~lso remember that not al I immigrants meet the fol low-up 
requirements when they reach the U.S. Some cases get "lost 
in the paperwork. " and hea I th care workers never track down 
the immi9rants who were supposed to receive a fol low-up exam 
in the U.S. To add to the confusion. it must be noted that 
not all countries test accurately for Tuberculosis when they 
screen individuals who are applying for admission into the 
U.S. Finally. the reader should not overlook the i I legal 
immigLants who sneak into the U.S. without any testing at 
all (Iseman and Starke).) 
The rates of Tuberculosis in the United States are 
directly related to the rates of immigration. From 1977 to 
1979 foreign born people accounted for only 15% of the 
Tuberculcsis cases in the U.S. In 1993. however. 30% of al I 
Tuberculosis cases in the U.S. were reported by foreign born 
inaividuals. The rate of foreign born cases in 1993 was 
33.6 per 100.000 and rising while the U.S. born population 
had a steady rate of 8.1 per 100,000. The incidence of 




the west side of the U.S. than in the rest of the country. 
The majority of foreign born cases are contracted in the 
country of origin. This is known because 55% of the cases 
are diagnosed within the first 5 years after immigration and 
29.6% of the cases are diagnosed within one year after 
immigration. It is most I ikely that these cases are a 
result of the activation of a latent Tuberculosis infection 
(one that is present but shows no symptoms and is not 
contagious) as opposed to new cases of Tuberculosis that 
were acquired in the U.S. after immigration (Mckenna et al). 
In California il legal immigration has caused quite a 
di lemma for health care workers. California has large 
numbers of illegal immigrants from the southern border of 
the United States. Many of the immigrants come to the 
United States with health problems. including Tuberculosis. 
In order to control the large numbers of immigrants the 
state of California has developed something cal led 
Proposition 187 <Iseman and Starkes). 
This is a proposed law which would require all health 
professionals in the state of Cal ifornia to deny medical 
treatment. with the exception of emergency situations, to 
all i Ile9al immigrants. In addition health care workers 
must report al I suspected immigrants to the government 
officials. The law has been proposed with the hope that it 
wi]] hinoer new immigrants from coming to the U.S. The 
individuals in favor of the law fee] that some immigrants 
come to the U.S. specifically for health care reasons. 
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Those opposed to Proposition 187 feel that the immigrants 
wil I come to the U.S. regardless of this proposition because 
they come to the U.S. to improve their overal I quality of 
j lfe. not for health care itself (Iseman and Starke). 
11 legal immigration is a problem without Proposition 187 but 
there are other laws which prohibit immigration. If these 
laws are not working, then some critics ask why this 
proposal would make any difference. 
Health care workers wi I I be in a tough situation if 
this pro~osal becomes law. Health care workers wil I be 
forced to deny care to individuals in need or go against 
government regulations. If health care professionals choose 
to obey government regulations Tuberculosis could get out of 
hand in immigrant populations. These smal I outbreaks wil I 
eventually reach the general population of the U.S. and 
Tuberculosis will become even worse. 
The state of California. along with the rest of the 
country. needs to set priorities. Is it more important to 
control illegal immigration in the United States or control 
TUberculcsis worldwide? By denying health care to il legal 
immigcants we violate confidentiality and only hurt 
ourseives. Illegal immigration is a problem but control ling 
Tuberculosis deserves top priority in the author's opinion. 
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Tuoerculosis and Human Immunodeficiency Virus/Acquired 
Immune Deficiency Syndrome 
-Globally there were an estimated 5.6 million patients 
infected with Human Immunodeficiency Virus/Acquired Immune 
Deficiency Syndrome and Tuberculosis in the middle of 1994. 
It ha:3 been sa i d that" HI V has emerged as the most i mpor t an t 
risk factor for progression of dormant tuberculosis 
infect ion to clinical disease" (Ravigl ione et al). HIV has 
spread rapidly in developing nations along with 
tuberculcsis. The incidence of Tuberculosis cases that was 
directly related to HIV worldwide was 4.2%. In sub-Saharan 
Africa. 20% of the Tuberculosis cases are said to be caused 
by HIV infection alone. In many developing nations 
Tuberculcsis has become the number one opportunistic disease 
associated with HIV/AIDS (Raviglione et al). The impact 
that HIV/AIDS and Tuberculosis are having upon one another 
seems to tIe enocmOl)s. But: \"h,3.t ex,3.ctiy is trl.:it imp,j.ct':' Ho\·,. 
are the two diseases affecting one another? How can one 
define the relationship between HIV/AIDS and Tuberculosis? 
The possible relationship between Tuberculosis and 
HIV/AIDS has received wide publ lcity from the mass media. 
It is commonly thought that HIV/AIDS is causing the rise in 
TUbereulcsis cases. This is a misconception because in 
truth the influence that HIV/AIDS is having on Tuberculosis 
is sti I I being investigated. While doing research the 
author fcund only two articles with substantial data on this 
sUb.leet. It is important for health educators as well as 
the general PUb] ic to know the truth about what is being 
14 
learned so that misconceptions do not spread. HIV/AIDS 
patients already face discrimination and promoting false 
information about Tuberculosis could increase the negative 
feel ings toward HIV/AIDS patients. If society were to be 
mislead into believing that HIV/AIDS is an actual cause of 
the rise in TUberculosis cases people might tend to blame 
the victims of one disease for the spread of another. It 
would be possible for people to blame victims of HIV/AIDS 
for the rise of tuberculosis. Therefore, proper knowledge 
about the relationship between HIV/AIDS and Tuberculosis is 
essential. Knowing the facts wil I enable health 
professionals and the public to prevent both Tuberculosis 
and HIV/AIDS as well as promote understanding of the 
diseases separately and together. 
The first article on this particular subject focused 
on a stuay conducted in New York City. This city has 
experienced the largest rise in the country for both 
Tuberculosis cases and AIDS cases. Since both diseases 
began to increase at the same time and in the same area it 
was thought that a strong relationship between the two would 
be found (Journal of American Medical Association). 
The researchers found two possible reasons to explain 
why HIV positive patients might have an increased chance of 
developing TUberculosis. The first possibll ity is that as 
HIV infection progresses to AIDS. the immune systems become 
~eakeL. A weaker immune system is not able to defend itself 
against a variety of new infections. including Tuberculosis. 
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Therefore. a person who is HIV positive might be more 
susceptible to contracting Tuberculosis. The second reason 
that TUbecculosis cases ace high may be due to latent 
Tuberculosis infections. People may have latent 
Tuberculosis infection for a long period of time before the 
disease becomes active. An individual who has a compromised 
immune system. such as a person with AIDS, wil I not be able 
to maintain Tuberculosis at a latent level and the 
TUberculcsis infection then become clinically active. This 
seems to be the most I ikely cause for the high number of 
patients with both Tuberculosis and HIV/AIDS. The annual 
risk of infection <chance of an individual becoming infected 
with Tuberculosis in a year's time) in the United States is 
too low to account for the high number of cases of active 
Tuberculcsis found in this population. In other words. not 
enougn new infections are occurring to account for the 
number of new Tuberculosis cases found among in HIV positive 
individuals. In addition, 65% of the patients who are 
diagnosec with AIDS and Tuberculosis are diagnosed with both 
diseases within 6 months of each other. Tuberculosis is 
usually ciagnosed within 6 months before or after the 
diagnosis of AIDS. This evidence suggests that as HIV 
progresses to AIDS latent Tuberculosis becomes active 
<Journal of American Medical Association). 
The second study reviewed was conducted on the homeless 
population in San Francisco. California. This study focused 
on the influence of HIV/AIDS and Tuberculosis among the 
16 
--
nameless because in recent years both Tuberculosis and 
HIV/AIDS have qrown rapidly among this population subgroup 
in San Francisco. The researchers wanted to find out if the 
two diseases were related to one another or if it was merely 
a coincidence that both diseases were on the rise in the 
same sub-population group at the same point in time (Zolopo 
et a I) . 
The researchers discovered that while there was some 
overlap between the two diseases (some individuals were 
found to have both). there was little evidence that HIV 
positive persons were actually causing the rise of 
Tuberculosis. The study showed that it is possible for HIV 
positive individuals to be more susceptible to ne~ 
Tuberculosis infection. It was also found that it is also 
possible that patients with AIDS are more susceptible to 
3ctivation of latent Tuberculosis infection. However. 
although evidence pointed in this direction. researchers 
concluded that there is no sol id proof for either suspicion 
(Z010po et al). 
The main conclusion from this study was that HIV and 
Tuberculosis share some common risk factors. One risk 
factor is IV drug use. IV drug use leads to HIV/AIDS when 
needles are shared. It is possible that IV drug use may 
cause poer health In general which could inhibit one/s 
immune system and make a person more suscept ibl e to nevl or 
reactivated Tuberculosis. An IV drug user is susceptible to 




between HIV and Tuberculosis when the initial infection 
occur's. The second common risk factor for Tuberculosis and 
HI~/AIDS is length of homelessness. Those who were homeless 
for one month or less had a 39% prevalence rate for IV drug 
use while those who reported to be homeless for one year or 
longer were found to have a 49% prevalence of IV drug use. 
The longer a person was homeless the more I ikely he was to 
use IV drugs. The more a person used IV drugs the greater 
his/her risk was of developing tuberculosis and HIV/AIDS. 
In addition. the longer a person is homeless the more likely 
he is to stay in a shelter. Homeless people who had stayed 
in shelters were more likely to develop Tuberculosis. The 
longer one remained in the crowded facilities the greater 
risk one had for developing Tuberculosis. Women who had 
I ived in shelters were found to have 3 times greater risk 
for developing Tuberculosis than those who had not lived in 
a shelter (Zolopo et al). 
The HIV prevalence in the target population was similar 
to the prevalence in other populations with similar risk 
factors whereas Tuberculosis was much higher than the 
general population. especially in crowded areas. Crowded 
I iving areas and IV drug use were found to be common risk 
factors for both HIV/AIDS and Tuberculosis. This find. in 
~ddition to the compromised immune system found in patients 
with AIDS. could explain why people with AIDS often develop 
Tuberculosis. Therefore it has not been proven that 
HIV/AIDS and Tuberculosis are directly related to one 
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inother. It Is Possible that both dIseases share multiple 
risk factors and individuals with those risk factors are 
prone to both diseases simultaneously (Zolopo et al). 
The problem of HIV/AIDS combined with tuberculosis does 
not end here. Once Tuberculosis cases are identified the 
next step is to treat the tuberculosis infection. Patients 
with AIDS. however. are difficult to treat. Some patients 
do not respond to normal treatment while others may have 
adverse reactions to the medication. The Centers for 
Disease Control and Prevention and the American Thoracic 
Society ~ave recommended that treatment of individuals with 
HIV/AIDS and Tuberculosis include a minimum of 3 
medications. The treatment should always last at least 9 
months. Once an HIV/AIDS patient tests negative for 
Tuberculosis the treatment should continue for 6 full months 
afterwards. At the end of the 6 months when treatment has 
been completed. al I patients must be monitored for possible 
relapse (Journal of American Medical Association). 
~l I health professionals need to be fully aware of the 
problems associated with Tuberculosis patients and HIV/AIDS 
patients. It is important to understand how each disease 
influences the other. Knowing the facts and the myths 
surrounding HIV/AIDS and tuberculosis wil I benefit health 
professicnals and the general public. In order to fight the 
disease one must know what he/she is up against. Al I health 
professionals need to keep updated on further studies and 
findings in this area. No one knows the precise 
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relationship between HIV.'AIDS and Tuberculosis ana no one 
knows what the future holds for these diseases. When twc 
aiseases that are difficult to fight are combined. the 
eventual outcome wi] J likely involve both trouble and 
hardship. 
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-Future Programs and Goals 
-
In 1989 the Centers for Disease Control and Prevention 
(CDC) in Atlanta, Georgia, set a goal to eliminate 
tuberculosis by the year 2010. In order to achieve this 
goal the CDC designed a comprehensive program to fight 
tuberculosis (MMWR). In the United States it is mainly the 
responsibility of the state and local health departments to 
implement Tuberculosis eradication and prevention programs. 
There are three broad goals associated with el iminating 
Tuberculosis. The first goal is to identify and treat all 
patients with Tuberculosis. The second goal is to identify 
3nd screen people who have been in contact with infected 
people. The last goal is to screen high-risk populations 
for Tuberculosis. The CDC has identified 7 components to 
accompl ish these three goals: 
-conducting overal I planning and development of 
policies to help eradicate Tuberculosis 
-identifying persons who have cl inical ly active 
Tuberculosis 
-managing persons who have or who are suspected of 
having disease 
-Identify and manage people with M. Tuberculosis 
-providing laboratory and diagnostic services 
-collecting and analyzing data, and 
-prcviding training and education. 
In the fol lowing paragraphs a brief description of 
each of the seven components and the major sub-components 
involved will be presented (MMWR). 
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Conducting overa}} planning and development of policy. 
Tuberculosis programs should be made up of coal itions 
- of health care providers. physicians, and a variety of 
health organizations in the community. The coalition should 
set up policies and strategies using the local Tuberculosis 
morbidity data. The coal ition is responsible for al I 
activities. funding, and providing guidance to health care 
~orkers in regards to Tuberculosis control and prevention. 
The coalition needs to review legislation and public 
pol icies to ensure that they are consistent with the goal of 
el iminating Tuberculosis. Examples of supportive 
legislation are: 
-treating patients without considering their abil ity to 
pay 
-protect the health of the public by isolating and 
treating patients with infectious Tuberculosis. and 
-st3te and local laws that regulate and protect patient 
confidentiality. 
The coal ition is also responsible for maintaining a 
staff that is ful ly trained and large enough to implement an 
effective program. The size of the staff wi I I vary 
depending! on the size and the need of each community. The 
staff may include a manager or director, epidemiologists. 
physicians. nurses. and community outreach people. The 
community outreach individuals may be trained volunteers or 
paid health professionals. Their main Job is to help 
undertake fol low-up visits. educate patients. ensure 
comp)etlon of treatment. serve as interpreters. or even 
-provide transportation to patients in need. The final 
responsibil ity of the coalition is to ensure sufficient 
funding for the needed Tuberculosis programs. The funds may 
come from federal. state, or local monies as well as private 
organizations. 
Identify people who have clinically active Tuberculosis. 
This component requires that programs provide methods 
of testing for Tuberculosis. The program must have trained 
people to test for Tuberculosis and read the results of 
tests accurately. Identifying cases often occurs when a 
patient visits the doctor about symptoms of tuberculosis. 
At this time the Tuberculosis is active and contagious. 
When a person is identified in this manner the next step is 
to identify close contacts to the patient who may have 
contracted Tuberculosis. In addition to contact 
investigations. programs need to have mandatory testing 
sites. or routine screening sites for high risk populations. 
Managing persons who have disease or who are suspected of 
having the disease. 
This component of the Tuberculosis el imination program 
has 8 requirements. Below is an outline taken from the MMWR 
printed by the CDC. The first step assigns the staff 
members to specific tasks. The second part evaluates the 
patient and determines the proper treatment for a particular 
patient. Next comes the actual treatment. Once the therapy 
has begun the workers must monitor the patient to ensure 
that the medications are working properly without adverse 
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side effects. The health care worker must see to it that 
any barriers to effective treatment are removed or avoided. 
The health care worker may even need to provide incentives 
to encourage the patient's adherence to the treatment. 
Educating the patient and providing helpful social services 
to the patient are also part of the plan. Finally. a 
fol low-up plan must be implemented to be sure the treatment 
cured the patient. 
Identify and manage people with M. Tuberculosis. 
This component is aimed at identifying individuals with 
latent Tuberculosis. This can be done by assessing the 
community and determining the prevalence of various groups. 
Once sub-populations at high risk for Tuberculosis infection 
are identified. the program should test them. After cases 
have Deen identified within the high risk groups it is 
essential to undertake a contact investigation. Contact 
investigations identify and test individuals who may have 
been exposed to Tuberculosis. Those who have come into 
contact with an infected individual may have become 
infected. A contact investigation is the best way to 
identify cases of Tuberculosis before symptoms appear. It 
should be noted that screening low risk groups should be 
avoided to save time. energy, and resources. In order to be 
effective in this component. it is necessary to work closely 
with as ~any local health agencies as possible. Health care 
workers cf high risk populations should be educated and 
trained to screen for Tuberculosis. 
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Laboratory and diagnostic services. 
AI I programs need to have equipment to test for 
Tuberculosis. Access to radiography equipment and trained 
workers to operate equipment and read the results are 
necessary. It would be best if results could be obtained 
within 24 hours of testing. Access to a mycobacterium 
laboratory is also a necessity. All programs also need 
services to assess drug toxicity and conduct monthly 
evaluations of al I Tuberculosis patients. This component 
also strongly suggests that al I Tuberculosis infected 
persons should be offered HIV counsel ing and testing. Staff 
members who work with Tuberculosis in populations at high 
risk for HIV should also receive HIV training. 
Data collection and analysis. 
The first recommendation in this component is effective 
communication among hospitals. physicians, health 
departments. and other health agencies in the community. 
Al I new Tuberculosis cases must be reported to the local 
health department. Al I programs need to keep a registry, or 
log. of al I Tuberculosis cases in the community. This keeps 
track of check-ups, problems. and progress for individual 
cases. Even though this registry must be kept, al I programs 
must maintain confidentiality of all patients. especially 
patients who are HIV positive. Programs must monitor and 
report al I drug resistant and multi-drug resistant 
tUberculosis cases. A yearly report must be made to 
evaluate program effectiveness and determine program needs. 
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One important record that must be kept is a record of al I of 
the deaths due to Tuberculosis. The program must evaluate 
each death and determine if it was preventable or not. Al I 
of the records and annual reports need to be forwarded to 
the CDC. 
Training and education. 
Al I staff members must be trained and their education 
must be continuously updated. It is the responsibility of 
the health department/s program to monitor the knowledge 
levels of the physicians. nurses. workers. and other 






When I began researching this paper I had no idea what 
I would come across. I knew what Tuberculosis was and I was 
~lso aware that the number of Tuberculosis cases is rising. 
My goal was to understand why Tuberculosis was becoming a 
problem and what can be done about this problem. 
I learned that Tuberculosis was slowly decreasing unti I 
the 1980's. During that time many health professionals and 
government officials felt that Tuberculosis was under 
control and it would eventually disappear. Attention and 
money switched from Tuberculosis to HIV/AIDS research. As a 
result of wide neglect. Tuberculosis is now making a 
comeback. This time, however. Tuberculosis is more 
compl icated. Tuberculosis is compl icated by drug resistant 
strains of Tuberculosis, HI~/AIDS. and migration . 
Developing nations that once may have received aid to 
control Tuberculosis are no longer receiving help. World 
leaders ~ade the mistake of thinking that 'declining cases' 
meant 'we have fixed the problem.' Now developing nations 
have unnecessarily high morbidity and mortality rates 
resulting from Tuberculosis. Treatment programs al 1 around 
the world are fai I ing to maintain proper treatment regimens 
which has resulted in drug resistant Tuberculosis. Finally. 
patients infected with both HIV/AIDS and Tuberculosis are 
increasing. Doctors are stil I trying to define the 
connection between the two diseases. 
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If Tuberculosis had been eradicated years ago. or if 
publ ic health professionals and worldwide leaders had 
persisted in their efforts to eliminate Tuberculosis, then 
the fight that the world is currently involved in would be 
non-existent. What is done is done. Now it is essential to 
attack T~berculosis and all of the compl ications that go 
along with the disease. Treatment and education programs 
need to be implemented by every health department in the 
United States. Nations must bond together and fight 
Tuberculosis. Tuberculosis is something that can be 
controlled and even eliminated. Eradicating Tuberculosis is 
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